Thelma Therapeutics (XKRX:015540) Short-Term Capital Lease Obligation : ₩42 Mil (As of Sep. 2022)

View and export this data going back to 1989. Start your Free Trial

What is Thelma Therapeutics Short-Term Capital Lease Obligation?

Thelma Therapeutics's Short-Term Capital Lease Obligation for the quarter that ended in Sep. 2022 was ₩42 Mil.

Thelma Therapeutics's quarterly Short-Term Capital Lease Obligation declined from Mar. 2022 (₩118 Mil) to Jun. 2022 (₩42 Mil) and declined from Jun. 2022 (₩42 Mil) to Sep. 2022 (₩42 Mil).

Thelma Therapeutics's annual Short-Term Capital Lease Obligation increased from Dec. 2019 (₩278 Mil) to Dec. 2020 (₩382 Mil) but then declined from Dec. 2020 (₩382 Mil) to Dec. 2021 (₩88 Mil).

Thelma Therapeutics Short-Term Capital Lease Obligation Historical Data

The historical data trend for Thelma Therapeutics's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thelma Therapeutics Short-Term Capital Lease Obligation Chart

Thelma Therapeutics Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Short-Term Capital Lease Obligation

Get a 7-Day Free Trial

278.34

381.65

88.46

Thelma Therapeutics Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial															215.08	88.46	117.75	42.38	41.68

Thelma Therapeutics Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Thelma Therapeutics Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Thelma Therapeutics's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Thelma Therapeutics (XKRX:015540) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Business Services » Thelma Therapeutics (XKRX:015540) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

N/A

Address

Mapo-gu, Seoul Sangam DMC Prugio City, 25, World Cup Buk-ro 54-gil, Seoul, KOR

Website

http://www.medi-plant.co.kr

Thelma Therapeutics, formerly Medipartner Biotechnology is a South Korean company engaged in providing hospital management support, dental material distribution, medical devices manufacturing, and development of new materials.

Thelma Therapeutics (XKRX:015540) Headlines

No Headlines